A new model for curing disease
We are an alliance of patients, caregivers, doctors, researchers, drug developers and entrepreneurs pioneering a new approach to curing diseases through innovative outcome-based financing.
We educate, motivate and collaborate with impact investors and payers to discover life-altering therapies and bring them to patients.
Our Target is Chronic Pancreatitis
The first disease we are attacking is pancreatitis. The world’s top pancreatic experts believe a well-funded, coordinated research and development program could lead to effective treatments.
Mission: Cure is working to make that happen. Consulting with pancreatic experts from the world’s top research and healthcare institutions, we developed a plan and are working to implement it.
Our Approach
Financing Based on Patient Outcomes
Promising and Cost-Effective Methods to Cure Diseases
Active Collaboration Among Stakeholders
Partnerships with Impact Investors
We cannot do this without your support.
The time is right to create a new model for curing disease. Exciting developments in genetics and data are making precision medicine a reality.
Healthcare payers are moving toward value-based funding, especially for chronic diseases. And a new generation of impact investors — seeking to generate social and not just financial returns — have made curing disease a priority.
Latest News
Pancreatitis-Friendly Halloween Treats
Halloween can be a challenging time for those managing pancreatitis, but with some careful planning, you can still enjoy the festive spirit without compromising your
Type 3c Diabetes Q&A
Dr. Melena Bellin, MD is a leading endocrinologist with over 20 years of experience. She presented on Mission: Cure’s Pancreatitis Patient Webinar, ‘Understanding Type 3c
Pancreatitis and Periods: Does Menstruation Affect Patients?
Have you ever wondered if your pancreatitis flares may be connected to your monthly periods? You’re not alone in making this connection. While menstrual cycles are part